Which of the two leading generics in the Indian market has the best clinical trials?
In a bid to combat the “medical-speak” problems plaguing Indian generics, India has been testing new drugs from two of the top players in the industry.In a joint report, HealthInfoIndia and Medical Technology Monitor India (MTRI) analysed the clinical trials for four Indian genericoins: Ruparibin, Rupaginal, Dronabinol, and Nurofen, and found the results were generally…